Italy - Larus Pharma S.r.l.

Larus Pharma S.r.l., located in Milan, Italy, is an emerging international player focusing on the development and commercialization of innovative health care products based on natural ingredients, such as essential oils and herbal extracts. Larus Pharma's product portfolio includes Cer'8®, a range of clinically certified adhesive patch products designed to combat mosquitoes and moths. The patches contain essential oils in patented microcapsules that are embedded in small sponge-type plasters and are suitable for use by all ages (including infants and toddlers). Larus Pharma's product range also includes cosmetic products for the relief of muscular pain in children (Lenidrin®) and for the relief of the swollen legs for pregnant women (SenzaZZZ® Invigorating and repellent gel). Notably, Larus Pharma is working closely with University Laboratories and contract research organizations in a continuous effort to enhance its products and provide new solutions to its customers. The company's traditional centre of operations is the Italian market -where the company serves pharmacies, parapharmacies, mass market organizations, and natural stores via highly competent and dedicated selling forces. In recent years, Larus Pharma has been continuously expanding to new territories in Europe, Middle East, Hong Kong and China. Taking advantage of the extensive Gerolymatos International network, Larus Pharma aims to introduce its product portfolio to new territories and capture increasing market shares in the imminent future.

Italy - Foltène Laboratories S.p.A.

Foltene Laboratories S.p.A., located in Milan, Italy, was originally a subsidiary of Crinos Industria Farmacobiologica S.p.A., an Italian pharmaceutical company founded in 1944. Currently, part of the Gerolymatos International corporate network, Foltène® laboratories are recognized as a major global player with a long tradition in the development and commercialization of innovative safe and effective cosmetic hair products. The laboratory’s key brands include anti-hair loss treatments for men and women based on the natural mucopolysaccharide mixtures Tricosaccaride® and Tricalgoxyl®. These unique products -present in the pharmacy channel under the Foltène® Pharma brand- capitalize on experience derived through more than 50 years of research and 39 published clinical trials, and have received global recognition placing Foltene in a strong market position in several markets. Notably, Foltène® Pharma comprises a complete range of hair-care products (treatments, shampoos, conditioners and food supplements) and specific cosmetic solutions for eyelashes and nails. Foltène®’s recent developments include a unique foam formulation of the anti-hair loss treatments for men and women that have already been launched in a number of markets including the USA in early 2010. Foltène Laboratories is currently investing heavily in the extensive revival of its product range, envisioning the expansion of its international presence. These efforts are expected to bear fruits within 2012.

Turkey - Genesis Ilaç S.A.

Genesis Ilaç, located in Istanbul, Turkey, was founded in 2000. Since then, Genesis Ilaç has experienced continuous growth both in terms of size and in market share offering a unique portfolio of proprietary and in-licensed products to its customers. Currently, Genesis Ilaç –with a headcount of over 80 employees- maintains a strong marketing force comprising of two sales teams and six area managers, managed from its Istanbul headquarters. The company serves key therapeutic categories and details several medical specialties including pediatricians, GPs, internists, dermatologists, oncologists and ENTs. Key products in the portfolio of Genesis Ilaç include Sinomarin® (Gerolymatos International), Actiq® (Cephalon), Rinopanteina®, Colinox®, Stomatovis® (DMG), Mentopin®, Calcimed D3®, Cevitt®, Magnesium® (Hermes Pharmaceutical) and DeNol® (Astellas). Genesis Ilaç's business plans focus on the successful introduction of several new product lines in 2011-2012, thus ensuring continuous double-digit growth in the forthcoming years.

Hong Kong - Genesis Labs Ltd.

Genesis Labs Ltd. located in Hong Kong, China, was founded in 2007 as a joint venture between Gerolymatos International S.A. and Profex Inc. with an aim to promote, sell and distribute proprietary and in-licensed products in the South East Asian markets. Over the last 3,5 years, Genesis Labs has continuously expanded its operations and is currently covering most markets in the area, namely, Hong Kong, China, Macau, Singapore, Malaysia, Korea, Vietnam and Taiwan. Genesis Labs's continuous growth has led to a steady increase in market share in all territories capitalizing on a unique product portfolio comprising of products in three categories: Health Care: Sinomarin® (Gerolymatos International), FreeCol® (Dietetics Pharma); Skin Care: Foltène® (Foltene Labs), Olivia® (Papoutsanis), Dermaglow® (VitalScience Corp); Personal Care: StopBleed® (Alltracel), Skeeter®, Decongestant Patch®, Mosquitout® (Larus Pharma). The primary objective of Genesis Labs in the imminent future is to further expand its market share in existing territories and its territorial coverage, offering an extended mix of unique products to its customers.

France* - Laboratoire A.I.M.

Laboratoire A.I.M., located in Paris, France, was founded in 2005, following the acquisition of Laboratoire A.I.M. The company offers branded and generic pharmaceuticals and over-the-counter healthcare products. The company currently commercializes mainly the brand Pulmofluide®, a cough mixture (acquired from Omega Pharma, France) and is available in the French market. Additional brands include Captafer® (food supplement that improves iron absorption) and Fullfast® (an appetite control spray), licensed from Medestea Biotech S.p.A, that have been launched in France during 2010. Laboratoire A.I.M., is also controlling production of the filtered sea water pumped from an offshore installation in Cancale, on the French coast of Brittany. The source is used in all seawater based products of the company's portfolio, including Sinomarin® and EARinse®, in addition to being used to pump sea water for other well-known nasal spray brands. It is one of the few seawater sources operating under the license and control of the French Water Authorities and satisfying the standards imposed by the French Ministry of Health. The seawater is thus unquestionably pure and its quality guaranteed. * International Corporate Network